Adherence to antiretroviral therapy (ART) during the early months of treatment in rural Zambia: influence of demographic characteristics and social surroundings of patients

Yuri Sasaki, Kazuhiro Kakimoto, Christopher Dube, Izukanji Sikazwe, Crispin Moyo, Gardner Syakantu, Kenichi Komada, Shinsuke Miyano, Naoko Ishikawa, Kiyoshi Kita, Ichiro Kai, Yuri Sasaki, Kazuhiro Kakimoto, Christopher Dube, Izukanji Sikazwe, Crispin Moyo, Gardner Syakantu, Kenichi Komada, Shinsuke Miyano, Naoko Ishikawa, Kiyoshi Kita, Ichiro Kai

Abstract

Background: Around 70% of those living with HIV in need of treatment accessed antiretroviral therapy (ART) in Zambia by 2009. However, sustaining high levels of adherence to ART is a challenge. This study aimed to identify the predictive factors associated with ART adherence during the early months of treatment in rural Zambia.

Methods: This is a field based observational longitudinal study in Mumbwa district, which is located 150 km west of Lusaka, the capital of Zambia. Treatment naive patients aged over 15 years, who initiated treatment during September-November 2010, were enrolled. Patients were interviewed at the initiation and six weeks later. The treatment adherence was measured according to self-reporting by the patients. Multiple logistic regression analysis was performed to identify the predictive factors associated with the adherence.

Results: Of 157 patients, 59.9% were fully adherent to the treatment six weeks after starting ART. According to the multivariable analysis, full adherence was associated with being female [Adjusted Odds Ratio (AOR), 3.3; 95% Confidence interval (CI), 1.2-8.9], having a spouse who were also on ART (AOR, 4.4; 95% CI, 1.5-13.1), and experience of food insufficiency in the previous 30 days (AOR, 5.0; 95% CI, 1.8-13.8). Some of the most common reasons for missed doses were long distance to health facilities (n = 21, 53.8%), food insufficiency (n = 20, 51.3%), and being busy with other activities such as work (n = 15, 38.5%).

Conclusions: The treatment adherence continues to be a significant challenge in rural Zambia. Social supports from spouses and people on ART could facilitate their treatment adherence. This is likely to require attention by ART services in the future, focusing on different social influences on male and female in rural Zambia. In addition, poverty reduction strategies may help to reinforce adherence to ART and could mitigate the influence of HIV infection for poor patients and those who fall into poverty after starting ART.

Figures

Figure 1
Figure 1
Description of study sample.

References

    1. Isaakidis P, Raguenaud ME, Te V, Tray CS, Akao K, Kumar V. et al.High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia. J Int AIDS Soc. 2010;13:11. doi: 10.1186/1758-2652-13-11.
    1. UNAIDS/WHO. UNAIDS Report on the Global AIDS Epidemic 2010. 2012. .
    1. WHO. Summary Country Profile for HIV/AIDS Treatment Scale-up. 2012. .
    1. Fylkesnes K, Ndhlovu Z, Kasumba K, Mubanga Musonda R, Sichone M. Studying dynamics of the HIV epidemic: population-based data compared with sentinel surveillance in Zambia. AIDS. 1998;12(10):1227–1234. doi: 10.1097/00002030-199810000-00015.
    1. UNAIDS/WHO. AIDS Epidemic Update 2009. 2012. .
    1. Ministry of Health, Zambia. Zambia Country Report. 2012. .
    1. UNAIDS. Zambia Epidemiological Fact Sheet on HIV and AIDS, 2009. 2012. .
    1. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH. et al.Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006;296(7):782–793. doi: 10.1001/jama.296.7.782.
    1. Ministry of Health, Zambia. Zambia Demographic and Health Survey 2007. 2012. .
    1. Ministry of Finance and National Planning. Fifth National Development Plan for 2006-2011. 2006. .
    1. Chi BH, Cantrell RA, Zulu I, Mulenga LB, Levy JW, Tambatamba BC. et al.Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia. Int J Epidemiol. 2009;38(3):746–756. doi: 10.1093/ije/dyp004.
    1. Birbeck GL, Chomba E, Kvalsund M, Bradbury R, Mang’ombe C, Malama K. et al.Antiretroviral adherence in rural Zambia: the first year of treatment availability. AmJTrop Med Hyg. 2009;80(4):669–674.
    1. Cantrell RA, Sinkala M, Megazinni K, Lawson-Marriott S, Washington S, Chi BH. et al.A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2008;49(2):190–195. doi: 10.1097/QAI.0b013e31818455d2.
    1. Carlucci JG, Kamanga A, Sheneberger R, Shepherd BE, Jenkins CA, Spurrier J. et al.Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr. 2008;47(5):615–622. doi: 10.1097/QAI.0b013e318165dc25.
    1. Grant E, Logie D, Masura M, Gorman D, Murray SA. Factors facilitating and challenging access and adherence to antiretroviral therapy in a township in the Zambian Copperbelt: a qualitative study. AIDS Care. 2008;20(10):1155–1160. doi: 10.1080/09540120701854634.
    1. Murray LK, Semrau K, McCurley E, Thea DM, Scott N, Mwiya M. et al.Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care. 2009;21(1):78–86. doi: 10.1080/09540120802032643.
    1. Nozaki I, Dube C, Kakimoto K, Yamada N, Simpungwe JB. Social factors affecting ART adherence in rural settings in Zambia. AIDS Care. 2011;23(7):831–838.
    1. Sanjobo N, Frich JC, Fretheim A. Barriers and facilitators to patients’ adherence to antiretroviral treatment in Zambia: a qualitative study. SAHARA J. 2008;5(3):136–143. doi: 10.1080/17290376.2008.9724912.
    1. Carrieri MP, Raffi F, Lewden C, Sobel A, Michelet C, Cailleton V. et al.Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study. Antivir Ther. 2003;8(6):585–594.
    1. Chêne G, Sterne JA, May M, Costagliola D, Ledergerber B, Phillips AN. et al.Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet. 2003;362(9385):679–686.
    1. WHO. HIV Testing, Treatment and Prevention: Generic Tools for Operational Research. 2012. .
    1. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B. et al.Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG) AIDS Care. 2000;12(3):255–266. doi: 10.1080/09540120050042891.
    1. WHO. WHO Case Definitions of HIV for Surveillance and Revised WHO Clinical Staging and Immunological Classification of HIV and Case Definition of HIV for Surveillance. 2012. .
    1. Kalichman SC, Simbayi LC, Cloete A, Mthembu PP, Mkhonta RN, Ginindza T. Measuring AIDS stigmas in people living with HIV/AIDS: the Internalized AIDS-Related Stigma Scale. AIDS Care. 2009;21(1):87–93. doi: 10.1080/09540120802032627.
    1. Alaimo K, Briefel RR, Frongillo EA Jr, Olson CM. Food insufficiency exists in the United States: results from the third National Health and Nutrition Examination Survey (NHANES III) Am J Public Health. 1998;88(3):419–426. doi: 10.2105/AJPH.88.3.419.
    1. Franke MF, Murray MB, Muñoz M, Hernández-Díaz S, Sebastián JL, Atwood S. et al.Food insufficiency is a risk factor for suboptimal antiretroviral therapy adherence among HIV-Infected adults in urban Peru. AIDS Behav. 2010;15(7):1483–1489.
    1. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S. et al.Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–690. doi: 10.1001/jama.296.6.679.
    1. Liu H, Miller LG, Hays RD, Golin CE, Wu T, Wenger NS. et al.Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. J Acquir Immune Defic Syndr. 2006;41(3):315–322. doi: 10.1097/01.qai.0000197071.77482.6e.
    1. Alibhai A, Kipp W, Saunders LD, Senthilselvan A, Kaler A, Houston S. et al.Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda. Int J Womens Health. 2010;2:45–52.
    1. WHO/UNAIDS/UNICEF. Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector. 2012. .
    1. Zolopa A, Andersen J, Powderly W, Sanchez A, Sanne I, Suckow C, Hogg E, Komarow L. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One. 2009;4(5):e5575. doi: 10.1371/journal.pone.0005575.
    1. Ofotokun I, Chuck SK, Hitti JE. Antiretroviral pharmacokinetic profile: a review of sex differences. Gend Med. 2007;4(2):106–119. doi: 10.1016/S1550-8579(07)80025-8.
    1. Wood SA, Tobias C, McCree J. Medication adherence for HIV positive women caring for children: in their own words. AIDS Care. 2004;16(7):909–913. doi: 10.1080/09540120412331290158.
    1. Eckman A, Blakley H, Anita B. How to Integrate Gender into HIV/AIDS Programs: Using Lessons Learned from USAID and Partner Organizations. Washington DC: Interagency Gender Working Group (IGWG) of USAID. 2012. .
    1. ICW. ICW Vision Paper 2: Access to Care, Treatment and Support (ACTS) 2012. .
    1. Human Rights Watch. Hidden in the Mealie Meal Gender-Based Abuses and Women’s HIV Treatment in Zambia. Human Rights Watch Volume 19. 2012. .
    1. Watt MH, Maman S, Earp JA, Eng E, Setel PW, Golin CE. et al.“It’s all the time in my mind”: facilitators of adherence to antiretroviral therapy in a Tanzanian setting. Soc Sci Med. 2009;68(10):1793–1800. doi: 10.1016/j.socscimed.2009.02.037.
    1. Stubbs BA, Micek MA, Pfeiffer JT, Montoya P, Gloyd S. Treatment partners and adherence to HAART in Central Mozambique. AIDS Care. 2009;21(11):1412–1419. doi: 10.1080/09540120902814395.
    1. Au JT, Kayitenkore K, Shutes E, Karita E, Peters PJ, Tichacek A. et al.Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda. AIDS. 2006;20(16):2116–2118. doi: 10.1097/01.aids.0000247580.16073.1b.
    1. Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T. et al.Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658–665. doi: 10.1080/09540120701244943.
    1. Birbeck GL, Kvalsund MP, Byers PA, Bradbury R, Mang’ombe C, Organek N, Kaile T, Sinyama AM, Sinyangwe SS, Malama K, Malama C. Neuropsychiatric and socioeconomic status impact antiretroviral adherence and mortality in rural Zambia. AmJTrop Med Hyg. 2011;85(4):782–789. doi: 10.4269/ajtmh.2011.11-0187.
    1. WFP. Zambia: WFP Activities. 2012. .
    1. Weiser SD, Tuller DM, Frongillo EA, Senkungu J, Mukiibi N, Bangsberg DR. Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS One. 2010;5(4):e10340. doi: 10.1371/journal.pone.0010340.
    1. Bhat VG, Ramburuth M, Singh M, Titi O, Antony AP, Chiya L. et al.Factors associated with poor adherence to anti-retroviral therapy in patients attending a rural health centre in South Africa. Eur J Clin Microbiol Infect Dis. 2010;29(8):947–953. doi: 10.1007/s10096-010-0949-4.
    1. Byakika-Tusiime J, Crane J, Oyugi JH, Ragland K, Kawuma A, Musoke P. et al.Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav. 2009;13(Suppl 1):82–91.
    1. Garang PG, Odoi RA, Kalyango JN. Adherence to antiretroviral therapy in conflict areas: a study among patients receiving treatment from Lacor Hospital, Uganda. AIDS Patient Care STDS. 2009;23(9):743–747. doi: 10.1089/apc.2009.0073.
    1. Krebs DW, Chi BH, Mulenga Y, Morris M, Cantrell RA, Mulenga L. et al.Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care. 2008;20(3):311–317. doi: 10.1080/09540120701594776.
    1. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P. et al.Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438. doi: 10.1371/journal.pmed.0030438.
    1. Mugusi F, Mugusi S, Bakari M, Hejdemann B, Josiah R, Janabi M. et al.Enhancing adherence to antiretroviral therapy at the HIV clinic in resource constrained countries; the Tanzanian experience. Trop Med Int Health. 2009;14(10):1226–1232. doi: 10.1111/j.1365-3156.2009.02359.x.
    1. Muyingo SK, Walker AS, Reid A, Munderi P, Gibb DM, Ssali F. et al.Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe. J Acquir Immune Defic Syndr. 2008;48(4):468–475. doi: 10.1097/QAI.0b013e31817dc3fd.
    1. Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE. et al.Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses. 2004;20(10):1053–1056. doi: 10.1089/aid.2004.20.1053.
    1. Olowookere SA, Fatiregun AA, Akinyemi JO, Bamgboye AE, Osagbemi GK. Prevalence and determinants of nonadherence to highly active antiretroviral therapy among people living with HIV/AIDS in Ibadan, Nigeria. J Infect Dev Ctries. 2008;2(5):369–372.
    1. Shah B, Walshe L, Saple DG, Mehta SH, Ramnani JP, Kharkar RD. et al.Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Infect Dis. 2007;44(9):1235–1244. doi: 10.1086/513429.
    1. Wang X, Wu Z. Factors associated with adherence to antiretroviral therapy among HIV/AIDS patients in rural China. AIDS. 2007;21(Suppl 8):S149–S155. doi: 10.1097/01.aids.0000304711.87164.99.
    1. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30(Suppl 2):S171–S176.
    1. Glass TR, De Geest S, Hirschel B, Battegay M, Furrer H, Covassini M. et al.Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antivir Ther. 2008;13(1):77–85.
    1. Shi L, Liu J, Koleva Y, Fonseca V, Kalsekar A, Pawaskar M. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmaco Econ. 2010;28(12):1097–1107. doi: 10.2165/11537400-000000000-00000.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa